-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
RAPT Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
- RAPT Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$27.7M, a 9.43% decline year-over-year.
- RAPT Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$120M, a 22% decline year-over-year.
- RAPT Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$117M, a 39.3% decline from 2022.
- RAPT Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$83.8M, a 21.1% decline from 2021.
- RAPT Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$69.2M, a 30.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)